InsightAce Analytic Pvt. Ltd. Announces the release of a market assessment report on the “Synthetic Biology Market”-, By Product (Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids, Chassis Organism), By Technology (NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology), By Application (Healthcare, Clinical, Bio/Pharmaceuticals, Diagnostics, Non-Clinical, Non-healthcare, Biotech Crops, Specialty Chemicals, Bio-fuels), By End Use (Biotechnology and Pharmaceutical companies, Academic and Research Institutes), and Global Forecasts, 2025-2034 And Segment Revenue and Forecast To 2034.”
The Synthetic Biology Market is estimated to reach over USD 97.66 Bn by the year 2034, exhibiting a CAGR of 18.8% during the forecast period.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2899
Synthetic biology represents an advanced interdisciplinary field dedicated to the re-engineering of biological organisms for practical applications across diverse industries, including manufacturing, agriculture, and healthcare.
The primary objective of synthetic biology is to redesign organisms to perform specific functions, such as producing high-value compounds like biofuels and pharmaceuticals, or acquiring new capabilities, such as environmental sensing. Notable examples include genetically engineered rice enriched with beta-carotene, yeast strains developed to synthesize rose oil, and microbes engineered for environmental remediation.
The market is experiencing robust growth, largely propelled by the increasing adoption of synthetic biology in agriculture. This technology enables enhanced crop productivity on reduced land areas, surpassing the capabilities of conventional genetic modification methods. In the healthcare sector, synthetic biology is contributing significantly to the development of improved diagnostic tools and the creation of more effective and safer therapeutic solutions, thereby accelerating market expansion.
Next-Generation Sequencing (NGS) technologies are playing a pivotal role in advancing synthetic biology by facilitating rapid and cost-effective genome sequencing. These tools allow researchers to validate genome editing, detect off-target modifications, and ensure the accuracy of engineered genetic changes—key requirements in applications such as gene therapy, agricultural biotechnology, and pharmaceutical development. Within agriculture, NGS supports the mapping of crop genomes, identification of advantageous genetic traits, and monitoring of genetic alterations, leading to the creation of high-yield, pest-resistant, and climate-resilient crops essential for sustainable farming.
Moreover, the integration of artificial intelligence (AI) and machine learning with synthetic biology is accelerating research and development efforts. These technologies enable the efficient analysis of large-scale genomic datasets, predict gene functionality, and assist in designing optimized genetic circuits. AI-driven tools improve R&D productivity by streamlining synthetic pathway design, minimizing experimentation time, and forecasting the behavior of engineered biological systems.
List of Prominent Players in the Synthetic Biology Market:
- Bota Biosciences Inc.
- Codexis, Inc.
- Creative Biogene.
- Creative Enzymes.
- Enbiotix, Inc.
- Illumina, Inc.
- Merck Kgaa
- New England Biolabs
- Eurofins Scientific
- Novozymes
- Pareto Bio, Inc.
- Scarab Genomics, Llc
- Synthego
- Synthetic Genomics Inc.
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Twist Bioscience
- BioBricks Foundation
- DIYbio
- Amyris
- Cyrus Biotechnology
- TeselaGen
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02
Market Dynamics
Drivers:
The growing emphasis on environmental sustainability is significantly contributing to the demand for bio-based alternatives to traditional fossil-fuel-derived products. Synthetic biology plays a pivotal role in facilitating the development of renewable bioplastics, biofuels, and biodegradable materials, thereby supporting the global transition toward eco-friendly solutions across multiple industries.
In the healthcare sector, synthetic biology is fostering innovation through the advancement of personalized medicine, gene therapy, and cell-based treatments. Engineered biological systems are also enabling progress in diagnostic technologies and vaccine development, further driving market expansion.
Additionally, increased financial support from government initiatives, venture capital firms, and private investors is accelerating research and development in synthetic biology. This influx of funding is expediting the commercialization of new technologies and encouraging both emerging companies and established industry participants to scale up their innovations.
Challenges:
Despite its transformative potential, synthetic biology faces considerable technical challenges. The design and optimization of synthetic organisms demand interdisciplinary expertise and significant research and development investment. High costs associated with advanced technologies such as precision gene editing, metabolic pathway engineering, and extensive validation processes can present substantial barriers, particularly for small and mid-sized enterprises.
Regional Trends:
North America is expected to maintain the largest market share during the forecast period. This dominance is attributed to substantial funding from both government agencies and venture capital, a robust biotechnology and pharmaceutical industry, and a dynamic startup ecosystem.
The presence of leading research institutions and strategic collaborations between academia and industry further stimulates innovation in the region. In addition, synthetic biology is increasingly being integrated into national biosecurity and biodefense strategies in collaboration with government entities.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2899
Recent Developments:
- In Aug 2024, Agilent Technologies Inc. declared a deal with Sangon Biotech, and a ceremony to introduce the “Digital Demonstration Laboratory” was held at Agilent Technologies Shanghai (ATS), with representatives from both companies from China in attendance. The partnership will increase Sangon’s testing and analysis capabilities to better serve its clients by utilizing Agilent’s extensive product line and full workflow solutions. With an emphasis on fostering advancement in the fields of synthetic biology and multi-omics, they will jointly aggressively investigate cutting-edge solutions in application areas that are critical to the biomedical and diagnostics industries.
- In Sept 2023, TeselaGen Biotechnology declared that it is signed a new multi-year contract with Joint BioEnergy Institute (JBEI) to continue their partnership through 2027. JBEI is one of four Bioenergy Research Centers (BRC) of the U.S. Department of Energy (DOE) that carry out cutting-edge research on biofuels and bioproducts, under the direction of Lawrence Berkeley National Laboratory.
Segmentation of Synthetic Biology Market.
Global Synthetic Biology Market- By Product
- Oligonucleotide/Oligo Pools and Synthetic DNA
- Enzymes
- Cloning Technologies Kits
- Xeno-Nucleic Acids
- Chassis Organism
Global Synthetic Biology Market- By Technology
- NGS Technology
- PCR Technology
- Genome Editing Technology
- Bioprocessing Technology
- Other Technologies
Global Synthetic Biology Market – By Application
- Healthcare
- Clinical
- Bio/Pharmaceuticals
- Diagnostics
- Non-Clinical
- Non-healthcare
- Biotech Crops
- Specialty Chemicals
- Bio-fuels
- Others
Global Synthetic Biology Market – By End Use
- Biotechnology and Pharmaceutical companies
- Academic and Research Institutes
- Others
Global Synthetic Biology Market – By Region
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
